5 Simple Techniques For Antidepressant agent 5
MI-CP151 was a stage 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre review To judge various intravenous doses of sifalimumab, in adult individuals with dermatomyositis or polymyositis (NCT00533091). Principal demo targets were to evaluate the safety and tolerability of sifalimumab in dermatomyositis or polymyositis in